Fulgent Genetics Inc (FLGT)
Debt-to-capital ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 2,964 | — | — | — | 3,372 | — | — | — | — | 5,947 | 5,899 | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,136,100 | 1,258,700 | 1,259,760 | 1,264,450 | 1,266,680 | 1,277,050 | 1,304,760 | 1,306,130 | 1,158,750 | 1,036,780 | 912,729 | 801,566 | 569,387 | 186,955 | 87,043 | 81,372 | 82,777 | 54,526 | 51,142 | 49,961 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $2,964K ÷ ($2,964K + $1,136,100K)
= 0.00
The debt-to-capital ratio for Fulgent Genetics Inc has remained consistent at 0.00 in the most recent quarters of Q4 2023 and Q3 2023. This indicates that the company does not have any debt in relation to its capital structure during these periods. However, in Q1 2023, there was a slight increase in the ratio to 0.02, suggesting that a small portion of the company's capital was financed through debt. Overall, the trend over the past few quarters shows a low level of debt in relation to the company's capital, which may indicate a conservative approach to financing and a relatively strong financial position.
Peer comparison
Dec 31, 2023